8legs: Supreme court decision allowing telehealth mailing of mifepristone

#1 out of 120.15%

A “Scheme” Against Dobbs: SCOTUS Dissent Hints at Next Phase of Abortion Rights Fight

The Supreme Court preserved telehealth access to mifepristone while the case proceeds, allowing mail and pharmacy dispensing.
Conservative justices Clarence Thomas and Samuel Alito dissented, signaling future battles over abortion rights.
The article notes the Comstock Act could be used to restrict mailing abortion medications, despite its historical limits.
Advocates say the FDA’s safety review of mifepristone has become a politically charged issue.
The piece emphasizes mifepristone’s safety, noting a less than 1% risk of serious adverse events together with misoprostol.
The article mentions a 2025 FDA safety review of mifepristone and concerns about politicization of the process.
Guttmacher Institute officials caution the threat to access remains despite the ruling.
The Intercept stresses that opponents may use the Comstock Act to push a nationwide abortion ban.
The ruling allows continued access amid ongoing litigation over the Louisiana v. FDA case.
The story notes political dynamics around the midterms affecting abortion policy considerations.

Vote 0